TWO YEARS OF NEWBORN SCREENING FOR CYSTIC
FIBROSIS IN NORTH MACEDONIA: FIRST EXPERIENCE Fustik S1,*, Anastasovska V2, Plaseska-Karanfilska D3, Stamatova A1,
Spirevska L1, Pesevska M2, Terzikj M3, Vujovic M3 *Corresponding Author: Professor Stojka Fustik, M.D., Ph.D., Department for Cystic Fibrosis,
University Clinic for Pediatrics, Faculty of Medicine, University “Ss. Cyril and Methodius,” Vodnjanska
17, 1000 Skopje, Republic of North Macedonia. Tel.: +389-23-147-716; +389-75-705-369. Fax: +389-
23-129-027. E-mail: stojkaf@yahoo.com page: 41
|
REFERENCES
1. Smyth AR, Bell SC, Bojcin S, BryonM, Duff A,
Flume P, et al. European Cystic Fibrosis Society
standards of care: Best practice guidelines. J Cyst
Fibros. 2014; 13(Suppl 1): S23-S42.
2. Castellani C, Duff AJA, Bell SC, Heijerman HGM,
Munck A, Ratjen F, et al. ECFS best practice guidelines:
The 2018 revision. J. Cyst Fibros. 2018; 17(2): 153-178.
3. Castellani C, Southern KW, Brownlee K, Roelse
JD, Duff A, Farrell M, et al. European best practice
guidelines for cystic fibrosis neonatal screening. J
Cyst Fibros. 2009; 8(3): 153-173.
4. Travert G, Heeley M, Heeley A. History of newborn
screening for cystic fibrosis–The early years. Int J
Neonatal Screen. 2020; 6(1): 8.
5. Scotet V, Gutierrez H, Farrell PM. Newborn screening
for CF across the globe– Where is it worthwhile? Int
J Neonatal Screen. 2020; 6(1): 18.
6. Farrell PM, Rosenstein BJ, White TB, Accurso FJ,
Castellani C, Cutting GR, et al.; Cystic Fibrosis
Foundation. Guidelines for diagnosis of cystic fibrosis
in newborns through older adults: Cystic fibrosis foundation
consensus report. J Pediatr. 2008; 153(2): S4-S14.
7. Farrell PM, White TB, Howenstine MS, Munck A,
Parad RB, Rosenfeld M, et al. Diagnosis of cystic
fibrosis in screened populations. J Pediatr. 2017;
181(Suppl): S33-S44.e2.
8. Noveski P, Madjunkova S, Mircevska M, Plaseski
T, Filipovski V, Plaseska-Karanfilska D. SNaPshopt
assay for the detection of the most common mutations
in infertile men. PLoS One. 2014; 9(11): e112498.
9. Terzic M, Jakimovska M, Fustik S, Jakovska T,
Sukarova-Stefanovska E, Plaseska-Karanfilska
D. Cystic fibrosis mutation spectrum in North
Macedonia: A step toward personalized therapy.
Balkan J Med Genet. 2019; 22(1): 35-40.
10. Naehrlich L. The changing face of cystic fibrosis and
its implications for screening. Int J Neonatal Screen.
2020; 6(3): 54.
11. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng
L, Lai HC, et al. Early diagnosis of cystic fibrosis
through neonatal screening prevents severe malnutrition
and improves long-term growth. Wisconsin
Cystic Fibrosis Neonatal Screening Study Group.
Pediatrics. 2001; 107(1): 1-13.
12. Mak DYF, Sykes J, Stephenson AL, Lands LC. The
benefits of newborn screening for cystic fibrosis: The
Canadian experience. J Cyst Fibros. 2016; 15(3):
302-308.
13. Siret D, Bretaudeau G, Branger B, Dabadie A,
Dagorne M, David V, et al. Comparing the clinical
evolution of cystic fibrosis screened neonatally to
that of cystic fibrosis diagnosed from clinical symptoms:
A 10-year retrospective study in a French region
(Brittany). Pediatr Pulmonol. 2003; 35(5): 342-349.
14. Schluter DK, Southern KW, Dryden C, Diggle P,
Taylor-Robinson D. Impact of newborn screening on
outcomes and social inequalities in cystic fibrosis: A
UK CF registry-based study. Thorax. 2020; 75(2):
123-131.
15. Davies G, Stocks J, Thia LP, Hoo A-F, Bush A, Aurora
P, et al. Pulmonary function deficits in newborn
screened infants with cystic fibrosis managed with
standard UK care are mild and transient. Eur Respir
J. 2017; 50(5): 1700326.
16. Tridello G, Castellani C, Meneghelli I, Tamanini A,
Assael BM. Early diagnosis from newborn screening
maximises survival in severe cystic fibrosis. ERJ
Open Res. 2018; 4(2): 00109-2017.
17. Nshimyumukiza L, Bois A, Daigneault P, Lands L,
Laberge AM, Fournier D, et al. Cost effectiveness of
newborn screening for cystic fibrosis: A simulation
study. J Cyst Fibros. 2014; 13(3): 267-274.
18. Castellani C, Massie J, Sontag M, Southern KW.
Newborn screening for cystic fibrosis. Lancet Respir
Med. 2016; 4(8): 653-661.
19. Barben J, Castellani C, Dankert-Roelse J, Gartner
S, Kashirskaya N, Linnane B, et al. The expansion
and performance of national newborn screening programmes
for cystic fibrosis in Europe. J Cyst Fibros.
2017; 16(2): 207-213.
20. Munck A, Mayell SJ, Winters V, Shawcross A,
Derichs N, Parad R, et al. Cystic fibrosis screen positive,
inconclusive diagnosis (CFSPID): A new designation
and management recommendations for infants
with an inconclusive diagnosis following newborn
screening. J Cyst Fibros. 2015; 14(6): 706-713.
21. Southern KW, Barben J, Gartner S, Munck A,
Castellani C, Mayell SJ, et al. Inconclusive diagnosis
after a positive newborn bloodspot screening resultfor
cystic fibrosis; clarification of the harmonised
international definition. J Cyst Fibros. 2019; 18(6):
778-780.
22. Munck A. Inconclusive diagnosis after newborn
screening for cystic fibrosis. Int J Neonatal Screen.
2020; 6(1): 19.
23. Rusakow LS, Frank J, Accurso FJ. Immunoreactive
trypsinogen levels in infants with cystic fibrosis complicated
by meconium ileus. Screening. 1993; 2: 13-17.
24. Repeto T, Mergni G, Revenni N, Zavataro L, Braggion
C. Delay in meconium emission: Should it be considered
a risk for cystic fibrosis. [Abstract 46]. J Cyst
Fibros. 2011; 11(Suppl 1): S12-S46.
|
|
|
|
|
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|